Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth
Manisit Das(University of North Carolina at Chapel Hill), Leaf Huang(University of North Carolina at Chapel Hill)
Cited by 4
Related Papers
mRNA vaccine for cancer immunotherapy
|Molecular Cancer|2021|892
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
|Nature Communications|2018|402
PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery
|Nature Communications|2016|170